Loading…
Cytomegalovirus as a Novel Target for Immunotherapy of Glioblastoma Multiforme
Progress in the treatment of glioblastoma multiforme (GBM) over the last few decades has remained marginal and GBM is still universally fatal with short survival times after initial diagnosis. Much research is focused on finding new therapeutics for GBM and immune-based approaches have shown great p...
Main Authors: | Schuessler, Andrea, Walker, David G., Khanna, Rajiv |
---|---|
Format: | Online Article Text |
Language: | English |
Published: |
Frontiers Media S.A.
2014
|
Subjects: | |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4187613/ https://www.ncbi.nlm.nih.gov/pubmed/25340042 http://dx.doi.org/10.3389/fonc.2014.00275 |
Similar Items
-
Cellular immunotherapy directed against human cytomegalovirus as a novel approach for glioblastoma treatment
by: Schuessler, Andrea, et al.
Published: (2014) -
The Basis and Advances in Clinical Application of Cytomegalovirus-Specific Cytotoxic T Cell Immunotherapy for Glioblastoma Multiforme
by: Daei Sorkhabi, Amin, et al.
Published: (2022) -
Immunotherapy and Epigenetic Pathway Modulation in Glioblastoma Multiforme
by: Chin, Christopher, et al.
Published: (2018) -
Glioblastoma Multiforme: An Overview of Emerging Therapeutic Targets
by: Taylor, Olivia G., et al.
Published: (2019) -
Advances in Immunotherapy for Glioblastoma Multiforme
by: Huang, Boyuan, et al.
Published: (2017)